Principal Financial Group Inc Novo Nordisk A S Transaction History

Principal Financial Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $52,645 - $60,811	-824 Reduced 14.01%	5,057 $353,000
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $19,107 - $21,066	-300 Reduced 4.85%	5,881 $408,000
Q2 2020 Aug 05, 2020	BUY	$58.54 - $67.94 $58,540 - $67,940	1,000 Added 19.3%	6,181 $405,000
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $173,110 - $226,730	-3,500 Reduced 40.32%	5,181 $312,000
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $31,860 - $37,228	-639 Reduced 6.86%	8,681 $502,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $83,080 - $94,500	-2,000 Reduced 17.67%	9,320 $430,000
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $46,760 - $51,240	-1,000 Reduced 8.12%	11,320 $534,000
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $22,145 - $25,210	-500 Reduced 3.9%	12,320 $0
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $145,470 - $174,420	-3,000 Reduced 18.96%	12,820 $632,000
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $142,590 - $161,190	-3,000 Reduced 15.94%	15,820 $849,000
Q3 2017 Nov 02, 2017	BUY	$41.15 - $49.22 $774,443 - $926,320	18,820	18,820 $907,000

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.